From: A single-center retrospective study of factors related to the effects of intravenous glucocorticoid therapy in moderate-to-severe and active thyroid-associated ophthalmopathy
1 Received orbital radiotherapy, decompression surgery, or other immunosuppressive therapy within the previous 3 months or during ivGC therapy.
2 Abnormal heart, liver and kidney function.